BACKGROUND: Nosocomial transmission of tuberculosis remains an important public health problem. We created an in vivo air sampling model to study airborne transmission of tuberculosis from patients coinfected with human immunodeficiency virus (HIV) and to evaluate environmental control measures. METHODS: An animal facility was built above a mechanically ventilated HIV-tuberculosis ward in Lima, Peru. A mean of 92 guinea pigs were continuously exposed to all ward exhaust air for 16 months. Animals had tuberculin skin tests performed at monthly intervals, and those with positive reactions were removed for autopsy and culture for tuberculosis. RESULTS: Over 505 consecutive days, there were 118 ward admissions by 97 patients with pulmonary tuberculosis, with a median duration of hospitalization of 11 days. All patients were infected with HIV and constituted a heterogeneous group with both new and existing diagnoses of tuberculosis. There was a wide variation in monthly rates of guinea pigs developing positive tuberculin test results (0%-53%). Of 292 animals exposed to ward air, 159 developed positive tuberculin skin test results, of which 129 had laboratory confirmation of tuberculosis. The HIV-positive patients with pulmonary tuberculosis produced a mean of 8.2 infectious quanta per hour, compared with 1.25 for HIV-negative patients with tuberculosis in similar studies from the 1950s. The mean monthly patient infectiousness varied greatly, from production of 0-44 infectious quanta per hour, as did the theoretical risk for a health care worker to acquire tuberculosis by breathing ward air. CONCLUSIONS: HIV-positive patients with tuberculosis varied greatly in their infectiousness, and some were highly infectious. Use of environmental control strategies for nosocomial tuberculosis is therefore a priority, especially in areas with a high prevalence of both tuberculosis and HIV infection.
BACKGROUND: Nosocomial transmission of tuberculosis remains an important public health problem. We created an in vivo air sampling model to study airborne transmission of tuberculosis from patients coinfected with human immunodeficiency virus (HIV) and to evaluate environmental control measures. METHODS: An animal facility was built above a mechanically ventilated HIV-tuberculosis ward in Lima, Peru. A mean of 92 guinea pigs were continuously exposed to all ward exhaust air for 16 months. Animals had tuberculin skin tests performed at monthly intervals, and those with positive reactions were removed for autopsy and culture for tuberculosis. RESULTS: Over 505 consecutive days, there were 118 ward admissions by 97 patients with pulmonary tuberculosis, with a median duration of hospitalization of 11 days. All patients were infected with HIV and constituted a heterogeneous group with both new and existing diagnoses of tuberculosis. There was a wide variation in monthly rates of guinea pigs developing positive tuberculin test results (0%-53%). Of 292 animals exposed to ward air, 159 developed positive tuberculin skin test results, of which 129 had laboratory confirmation of tuberculosis. The HIV-positive patients with pulmonary tuberculosis produced a mean of 8.2 infectious quanta per hour, compared with 1.25 for HIV-negative patients with tuberculosis in similar studies from the 1950s. The mean monthly patient infectiousness varied greatly, from production of 0-44 infectious quanta per hour, as did the theoretical risk for a health care worker to acquire tuberculosis by breathing ward air. CONCLUSIONS:HIV-positive patients with tuberculosis varied greatly in their infectiousness, and some were highly infectious. Use of environmental control strategies for nosocomial tuberculosis is therefore a priority, especially in areas with a high prevalence of both tuberculosis and HIV infection.
Authors: Peng Xu; Elmira Kujundzic; Jordan Peccia; Millie P Schafer; Gene Moss; Mark Hernandez; Shelly L Miller Journal: Environ Sci Technol Date: 2005-12-15 Impact factor: 9.028
Authors: D A MITCHISON; A L BHATIA; S RADHAKRISHNA; J B SELKON; T V SUBBAIAH; J G WALLACE Journal: Bull World Health Organ Date: 1961 Impact factor: 9.408
Authors: Janet C Mohle-Boetani; Vanessa Miguelino; Daniel H Dewsnup; Edward Desmond; Evalyn Horowitz; Stephen H Waterman; Joseph Bick Journal: Clin Infect Dis Date: 2002-01-17 Impact factor: 9.079
Authors: A B Curtis; R Ridzon; L F Novick; J Driscoll; D Blair; M Oxtoby; M McGarry; B Hiscox; C Faulkner; H Taber; S Valway; I M Onorato Journal: Int J Tuberc Lung Dis Date: 2000-04 Impact factor: 2.373
Authors: L Caviedes; T S Lee; R H Gilman; P Sheen; E Spellman; E H Lee; D E Berg; S Montenegro-James Journal: J Clin Microbiol Date: 2000-03 Impact factor: 5.948
Authors: R M Ikeda; G S Birkhead; G T DiFerdinando; D L Bornstein; S W Dooley; G P Kubica; D L Morse Journal: Infect Control Hosp Epidemiol Date: 1995-03 Impact factor: 3.254
Authors: A Roderick Escombe; Clarissa C Oeser; Robert H Gilman; Marcos Navincopa; Eduardo Ticona; William Pan; Carlos Martínez; Jesus Chacaltana; Richard Rodríguez; David A J Moore; Jon S Friedland; Carlton A Evans Journal: PLoS Med Date: 2007-02 Impact factor: 11.069
Authors: Sanjay Basu; Gerald H Friedland; Jan Medlock; Jason R Andrews; N Sarita Shah; Neel R Gandhi; Anthony Moll; Prashini Moodley; A Willem Sturm; Alison P Galvani Journal: Proc Natl Acad Sci U S A Date: 2009-04-13 Impact factor: 11.205
Authors: Grant Theron; Jason Limberis; Rouxjeane Venter; Liezel Smith; Elize Pietersen; Aliasgar Esmail; Greg Calligaro; Julian Te Riele; Marianna de Kock; Paul van Helden; Tawanda Gumbo; Taane G Clark; Kevin Fennelly; Robin Warren; Keertan Dheda Journal: Nat Med Date: 2020-06-29 Impact factor: 53.440
Authors: Sean P Fitzwater; Luz Caviedes; Robert H Gilman; Jorge Coronel; Doris LaChira; Cayo Salazar; Juan Carlos Saravia; Krishna Reddy; Jon S Friedland; David A J Moore Journal: Clin Infect Dis Date: 2010-08-15 Impact factor: 9.079
Authors: A Roderick Escombe; David A J Moore; Robert H Gilman; Marcos Navincopa; Eduardo Ticona; Bailey Mitchell; Catherine Noakes; Carlos Martínez; Patricia Sheen; Rocio Ramirez; Willi Quino; Armando Gonzalez; Jon S Friedland; Carlton A Evans Journal: PLoS Med Date: 2009-03-17 Impact factor: 11.069
Authors: Laura E Via; Danielle M Weiner; Daniel Schimel; Philana Ling Lin; Emmanuel Dayao; Sarah L Tankersley; Ying Cai; M Teresa Coleman; Jaime Tomko; Praveen Paripati; Marlene Orandle; Robin J Kastenmayer; Michael Tartakovsky; Alexander Rosenthal; Damien Portevin; Seok Yong Eum; Saher Lahouar; Sebastien Gagneux; Douglas B Young; Joanne L Flynn; Clifton E Barry Journal: Infect Immun Date: 2013-05-28 Impact factor: 3.441